National Multiple Myeloma Survey: Prevalence and Treatment Outcomes in Nigeria

Thomas J O'Hare

Mechanisms of Resistance to Ponatinib Therapy in Chronic Myeloid Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Zhe Li

IGF/IGF1R signaling in hematopoiesis and leukemogenesis

Leukaemia

Javier Adachi

Genomic Characteristics of VRE Bloodstream Infection in Patients with Hematological Malignancies: Impact on Clinical Outcomes in Six Geographical Regions

Leukaemia

Hematology and hematologic malignancies

Henry Ddungu

The Optimal Use of Platelet Support Transfusion Among Patients with Hematological Malignancies in Uganda

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Richard Aplenc

Genetic Predictors of AML Treatment Response

Leukaemia

Hematology and hematologic malignancies Pediatric oncology or childhood cancer

Michele S Redell

Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML

Leukaemia

Hematology and hematologic malignancies

Kenneth Lynn Wright

Natural Killer Cell Regulation by PRDM1 and IRF4/8

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Demetrius Albanes

Heart Rate Consortium

Trachea, bronchus and lung Testis Stomach Prostate Pancreas Oesophagus Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Leukaemia Larynx Kidney, renal pelvis and ureter Colorectum Brain, nervous system Bladder

Vincent DeGennaro

National Cancer Treatment Program

Stomach Ovary Non-Hodgkin lymphoma Nasopharynx Leukaemia Larynx Kaposi sarcoma Hodgkin lymphoma Colorectum Breast